SHENZHEN CHIPSCREEN BIOSCIENCE has a total of 12 patent applications. Its first patent ever was published in 2003. It filed its patents most often in China, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are MEDIQUEST THERAPEUTICS INC, GRINDEKS JSC and NANJING HERON PHARMACEUTICAL SCIENCE AND TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Deng Tuo | 9 |
#2 | Shan Song | 9 |
#3 | Ning Zhiqiang | 9 |
#4 | Li Zhibin | 9 |
#5 | Lu Xian-Ping | 8 |
#6 | Shi Leming | 7 |
#7 | Liao Chenzhong | 5 |
#8 | Ma Baoshun | 5 |
#9 | Liu Zhende | 5 |
#10 | Li Boyu | 4 |
Publication | Filing date | Title |
---|---|---|
US7244751B2 | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity | |
AU2003276622A1 | Noncyclic 1,3-dicarbonyl compounds as dual ppar agonists with potent antihyperglycemic and antihyperlipidemic activity | |
CN1523004A | Vitamin A acid analogue and its preparing method and application | |
CN1515534A | Non-cyclic 1,3-dicarbonyl PPAR double-activation compound with sugar-reducing lipid-reducing activity and preparation method of its medicinal preparation | |
CN1562970A | PPAR full activator of amino acids of aralkyl possessing excellent activity for lowering sugar and ester |